Cryoport Inc
USUSDCryoport Inc (US:CYRX) — Biotechnology: Pharmaceutical Preparations. Number of exchanges where the company shares trade: 1. On this page — price and chart, dividends, top holders and share count history.
About the company
- Website
- cryoport.com
- Sector
- Health Care · Biotechnology: Pharmaceutical Preparations
- Headquarters
- BRENTWOOD, United States
- Management
- Latest reports
- Employees
- 684
- Shares outstanding
- Free float
- 45.95 M
- Market cap
- 822.03 M USD
- Insiders
- 3.86%
- Institutions
- 95.14%
- Industry (SIC)
- Pharmaceutical Preparations
- P/EP/E (Price / Earnings) — how many years of the company's profit you pay for a share. Calculated: current price ÷ net earnings per share over the last 12 months. Lower means cheaper relative to profit. Not calculated when the company has a loss (—).
- loss
- EPSEPS (Earnings Per Share) — the company's net profit over the last 12 months divided by the number of its shares, in the currency of this listing. A negative value (red) means a loss. P/E is the share price divided by EPS.
- −0.81 USD
- |P/B (price to book) — share price ÷ shareholders' equity per share from the latest balance sheet. Graham — as Benjamin Graham counted it: equity without goodwill, other intangible assets and preferred stock, that is tangible book value. He considered up to 1.5 acceptable for a defensive investor (green), or a product P/E × P/B up to 22.5. With negative tangible equity, Graham's P/B is not calculated.
- 1.682.48
- FCFFCF (Free Cash Flow) — money left to the company after operating costs and investment in equipment; dividends are safest when paid from it. Calculated: operating cash flow − capital expenditure, over the last 12 months, in the reporting currency.
- −18.8 M USD
- DebtDebt — all loans and bonds of the company per the latest report (short- and long-term), in the reporting currency. Below — how many years the company would need to repay net debt (debt minus cash) from its free cash flow: net debt ÷ FCF. Up to 3 years — good, 3–6 — moderate, over 6 — high. «Net cash» — net debt is negative.
- 947 K USDnet cash
- Earnings and FCF — for the 12 months to 30.09.2026 (the company's latest report).
- Net income
- NAVNAV — net asset value by the balance sheet: the company's assets minus its liabilities, the share of the company's shareholders (without other owners' stakes in its subsidiaries). Shown per share, with P/NAV — how many times the share price exceeds NAV per share (below 1 — the share costs less than its net assets on the balance sheet). Click to see what NAV is made of and its history.
Description
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
Exchanges and tickers
| Exchange | Ticker | Currency | Price | Type |
|---|---|---|---|---|
| US USA Stocks | CYRX | USD | 16.06 -3.83% | common stock |
News this week
Press releases from the company's investor website, updated daily. Links lead to the company's website. Headlines are in the original language, as on the company website.
Top holders
| Holder | Stake | Shares | Report date |
|---|---|---|---|
| Blackrock Inc. | 8.33% | 4.22 M | 2026-06-30 |
| Cadian Capital Managemen… | 5.77% | 2.92 M | 2026-06-30 |
| Morgan Stanley | 4.5% | 2.28 M | 2026-06-30 |
| Vanguard Capital Managem… | 4.25% | 2.15 M | 2026-06-30 |
| Millennium Management Ll… | 3.41% | 1.72 M | 2026-06-30 |
| Fred Alger Management, L… | 3.05% | 1.55 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.01% | 1.52 M | 2026-06-30 |
| Geode Capital Management… | 2.59% | 1.31 M | 2026-06-30 |
| iShares Trust-iShares Ru… | 2.53% | 1.28 M | 2026-09-30 |
| MAK Capital One LLC | 2.52% | 1.28 M | 2026-06-30 |
| First Eagle Investment M… | 2.51% | 1.27 M | 2026-06-30 |
| SHELTON JERRELL WILSON (… | ≈2.37% | 1.2 M | 2026-08-11 |
| First Eagle Funds-First… | 2.25% | 1.14 M | 2026-07-31 |
| ALGER FUNDS-Alger Small… | 2.11% | 1.07 M | 2026-07-31 |
| State Street Corporation | 2.07% | 1.05 M | 2026-06-30 |
| CALAMOS INVESTMENT TRUST… | 1.47% | 742 856 | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 1.14% | 578 058 | 2026-06-30 |
| Fidelity Salem Street Tr… | 1.07% | 542 032 | 2026-07-31 |
| TIAA-CREF Funds-Nuveen Q… | 1.01% | 511 730 | 2026-07-31 |
| Brown Capital Mgmt Mutua… | 0.99% | 502 162 | 2026-06-30 |
| iShares Trust-iShares Ru… | 0.91% | 461 316 | 2026-09-30 |
| STEFANOVICH ROBERT STEVE… | ≈0.22% | 109 850 | 2026-06-04 |
| ZECCHINI EDWARD J (Offic… | ≈0.22% | 109 719 | 2026-06-11 |
| SAWICKI MARK W (Officer) | ≈0.2% | 102 356 | 2026-03-23 |
| HANCOCK DANIEL M (Direct… | ≈0.14% | 69 052 | 2026-06-05 |
| BADDOUR LINDA (Director) | ≈0.13% | 68 099 | 2026-06-05 |
| MANDALAM RAMKUMAR (Direc… | ≈0.13% | 67 894 | 2026-06-08 |
| HARIRI ROBERT J (Directo… | ≈0.12% | 61 625 | 2026-06-05 |
Sign in with Google